Health and Wellness

Miracle baby: Preterm infant defies odds; overcomes two-month NICU battle

Miracle baby: Preterm infant defies odds; overcomes two-month NICU battle

The baby encountered numerous obstacles in the NICU, where she was immediately placed on a ventilator, followed by surfactant therapy…

April 7, 2025

Delhi woman dies in accident; her organs save many lives

According to the National Organ and Tissue Transplant Organisation (NOTTO), once a patient is declared brain dead, the hospital can…

April 1, 2025

Delhi: Family donates organs of brain dead woman, saves three lives

Family of 68-year-old Veena Jain chooses organ donation after doctors declare her brain dead at Max Hospital, Saket

March 28, 2025

RML Hospital’s contractual workers struggle due to unpaid dues

Nearly three dozen employees, facing mounting debts, have urged the administration to release their salaries

March 20, 2025

Delhi hospital performs 200 stem cell transplants in a year

Stem cell transplants are often a last resort for the patients with aggressive blood cancers like leukemia, lymphoma and multiple…

March 18, 2025

Kidney transplant crisis in India: Why cadaver donations remain alarmingly low

With an acute shortage of cadaver kidney donations, most transplant patients rely on living donors—leaving many on dialysis with little…

March 13, 2025

India’s growing kidney health crisis: Why it’s going unnoticed

A report from the Indian Society of Nephrology reveals that India has just one dialysis centre for every 3-lakh people,…

March 13, 2025

Delhi: 80-year-old woman donates kidney to save her son’s life

Despite concerns about her advanced age, medical evaluations confirmed that Darshana Jain was a suitable donor, paving the way for…

March 13, 2025

Delhi Air Pollution: Humidity may cause 20% underestimation, study reveals

Fine particulate matter in Delhi's winter air could be absorbing moisture, leading to an underestimation of PM1 pollution by up…

March 13, 2025

Yearly HIV prevention injection shows promise in clinical trial

'Lenacapavir' was developed by Gilead Sciences, a research-based biopharmaceutical company in the US, as a pre-exposure prophylaxis (PrEP) medication to…

March 12, 2025